Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes

British Journal of Haematology

Volumn 159, Issue 5, 2012, Pages 572-576

  Slager, Susan L ^a   Camp, Nicola J ^b   Conde, Lucia ^c   Shanafelt, Tait D ^a   Achenbach, Sara J ^a   Rabe, Kari G ^a   Kay, Neil E ^a   Novak, Anne J ^a   Call, Timothy G ^a   Bracci, Paige M ^d   Sille, Fenna M C ^c   Sanchez, Sylvia ^c   Akers, Nicholas K ^c   Cunningham, Julie M ^a   Serie, Daniel J ^a   McDonnell, Shannon K ^a   Leis, Jose F ^a   Wang, Alice H ^a   Weinberg, J Brice ^e,f   Glenn, Martha ^b   Link, Brian ^g   Vachon, Celine M ^a   Lanasa, Mark C ^e   Skibola, Christine F ^c   Cerhan, James R ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

BAK 1; Chronic lymphocytic leukaemia; Non Hodgkin lymphoma; Risk locus; Single nucleotide polymorphisms

Indexed keywords

ARTICLE; BAK1 GENE; CANCER RISK; CHROMOSOME 6P; CHROMOSOME VARIANT; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VALIDATION STUDY;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 6; DNA, NEOPLASM; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869082120     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12070     Document Type: Article

References (9)

1. Harris, N.L., Swerdlow, S., Campo, E., Jaffe, E.S., Stein, H., Pileri, S., Thiele, J. & Vardiman, J. (2008) The World Health Organization (WHO) classification of lymphoid neoplasms: what's new? Annals of Oncology, 19, 119.
2. Higgins, J.P. & Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539-1558.
3. Kumar, P., Henikoff, S. & Ng, P.C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols, 4, 1073-1081.
4. Lo, K.S., Wilson, J.G., Lange, L.A., Folsom, A.R., Galarneau, G., Ganesh, S.K., Grant, S.F., Keating, B.J., McCarroll, S.A., Mohler, E.R., III, O'Donnell, C.J., Palmas, W., Tang, W., Tracy, R.P., Reiner, A.P. & Lettre, G. (2011) Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Human Genetics, 129, 307-317.
5. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M. & DePristo, M.A. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research, 20, 1297-1303.
6. Slager, S.L., Rabe, K.G., Achenbach, S.J., Vachon, C.M., Goldin, L.R., Strom, S.S., Lanasa, M.C., Spector, L.G., Rassenti, L.Z., Leis, J.F., Camp, N.J., Glenn, M., Kay, N.E., Cunningham, J.M., Hanson, C.A., Marti, G.E., Weinberg, J.B., Morrison, V.A., Link, B.K., Call, T.G., Caporaso, N.E. & Cerhan, J.R. (2011) Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood, 117, 1911-1916.
7. Slager, S.L., Skibola, C.F., Di Bernardo, M.C., Conde, L., Broderick, P., McDonnell, S.K., Goldin, L.R., Croft, N., Holroyd, A., Harris, S., Riby, J., Serie, D.J., Kay, N.E., Call, T.G., Bracci, P.M., Halperin, E., Lanasa, M.C., Cunningham, J.M., Leis, J.F., Morrison, V.A., Spector, L.G., Vachon, C.M., Shanafelt, T.D., Strom, S.S., Camp, N.J., Weinberg, J.B., Matutes, E., Caporaso, N.E., Wade, R., Dyer, M.J., Dearden, C., Cerhan, J.R., Catovsky, D. & Houlston, R.S. (2012) Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood, 120, 843-846.
8. Soranzo, N., Spector, T.D., Mangino, M., Kuhnel, B., Rendon, A., Teumer, A., Willenborg, C., Wright, B., Chen, L., Li, M., Salo, P., Voight, B.F., Burns, P., Laskowski, R.A., Xue, Y., Menzel, S., Altshuler, D., Bradley, J.R., Bumpstead, S., Burnett, M.S., Devaney, J., Doring, A., Elosua, R., Epstein, S.E., Erber, W., Falchi, M., Garner, S.F., Ghori, M.J., Goodall, A.H., Gwilliam, R., Hakonarson, H.H., Hall, A.S., Hammond, N., Hengstenberg, C., Illig, T., Konig, I.R., Knouff, C.W., McPherson, R., Melander, O., Mooser, V., Nauck, M., Nieminen, M.S., O'Donnell, C.J., Peltonen, L., Potter, S.C., Prokisch, H., Rader, D.J., Rice, C.M., Roberts, R., Salomaa, V., Sambrook, J., Schreiber, S., Schunkert, H., Schwartz, S.M., Serbanovic-Canic, J., Sinisalo, J., Siscovick, D.S., Stark, K., Surakka, I., Stephens, J., Thompson, J.R., Volker, U., Volzke, H., Watkins, N.A., Wells, G.A., Wichmann, H.E., Van Heel, D.A., Tyler-Smith, C., Thein, S.L., Kathiresan, S., Perola, M., Reilly, M.P., Stewart, A.F., Erdmann, J., Samani, N.J., Meisinger, C., Greinacher, A., Deloukas, P., Ouwehand, W.H. & Gieger, C. (2009) A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nature Genetics, 41, 1182-1190.
9. Swerdlow, S.H. (2008) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues; Volume 2 of WHO Classification of Tumours Series. IARC, Lyon.